Close

Array Biopharma (ARRY) Submits Binimetinib NDA

June 30, 2016 4:01 PM EDT Send to a Friend
Array BioPharma (Nasdaq: ARRY) today announced the submission of a New Drug Application (NDA) for binimetinib in patients with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login